Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities
about
The economics of dementia-care mapping in nursing homes: a cluster-randomised controlled trialNon-pharmacological management of behavioural symptoms of dementia.Profile and variables related to antipsychotic consumption according to dementia subtypes.A systematic review of the predictors of health service utilisation by adults with mental disorders in the UK.Behavioural symptoms of dementia in residential settings: a selective review of non-pharmacological interventions.[Non-pharmacological treatment of dementia in geriatric psychiatry care units : Scoping review].Dementia care mapping: a review of the research literature.Enriching opportunities for people living with dementia: the development of a blueprint for a sustainable activity-based model.Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trial.Improving quality of care: focus on liaison old age psychiatry.Mental health service delivery in long-term care homes.Providing activity for people with dementia in care homes: a cluster randomised controlled trial.Comprehensive treatment of dementia with Lewy bodies.Top cited papers in International Psychogeriatrics: 6a. Quality of life for people with dementia living in residential and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skApplication of behavior-based ergonomics therapies to improve quality of life and reduce medication usage for Alzheimer's/dementia residents.Dementia Care Mapping as a research tool for measuring quality of life in care settings: psychometric properties.Treatment of Behavioral and Psychological Symptoms of Alzheimer’s Disease
P2860
Q28539232-DF028DFC-AA71-4B5F-9467-BA427ECBF8DEQ30409197-5E4A9B30-150E-4644-A5A3-F71EAFFEFF66Q34158495-6D2E8897-BE37-43EA-92D0-1B726DB7949FQ35844086-48E99C61-F2DB-4389-88F7-5F612E3FEE17Q36086070-81B3DF1A-0C0D-468F-B32F-7F2D623BBFBBQ36227100-A8B4BBA4-E383-455F-A1E9-36E951EB2B0CQ36288801-78871DA1-A091-476C-AEED-3EC94C2D0A4BQ36870969-220A245A-5F10-4A99-8ECF-DD9C36854E01Q37037989-F87B0648-E89A-4B67-A762-9A2092A39C9DQ37294160-713C47D4-1302-4CF5-9149-EB3581BD8ADBQ37766309-44E15EFC-7F06-4EFC-8D96-121FFD9175A9Q39426478-86D3560D-C785-4D8F-A32F-0C7D98A31953Q41317541-36F8910C-CBAB-43A3-A49D-D8FFB1B6A51AQ45808414-A63393DD-07D6-4580-9423-DB10A194976CQ48345390-00AB3669-1E28-4258-91C5-121464E4D673Q53410561-C4652540-5610-4FC3-8AE5-448B1B56B2EAQ57924698-C9A564E8-C569-4093-83B3-B5888E7C67C4
P2860
Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities
description
article
@en
im Jahr 2002 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2002
@uk
name
Can psychiatric liaison reduce ...... ts residing in care facilities
@en
Can psychiatric liaison reduce ...... ts residing in care facilities
@nl
type
label
Can psychiatric liaison reduce ...... ts residing in care facilities
@en
Can psychiatric liaison reduce ...... ts residing in care facilities
@nl
prefLabel
Can psychiatric liaison reduce ...... ts residing in care facilities
@en
Can psychiatric liaison reduce ...... ts residing in care facilities
@nl
P2093
P2860
P50
P356
P1476
Can psychiatric liaison reduce ...... ts residing in care facilities
@en
P2093
Alan Swann
Carol Bannister
Damian Robinson
Dawn Potkins
Ian Powell
Jay Shrimanker
Katharina Reichelt
Marisa Lana
P2860
P304
P356
10.1002/GPS.543
P407
P577
2002-01-01T00:00:00Z